United States

AIM ImmunoTech’s Ampligen Safety Data Presented at Eighth European Scientific Working Group on Influenza

OCALA, Fla., Dec. 09, 2021 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) today announced that safety data on its drug Ampligen was recently presented at the Eighth European Scientific Working Group on Influenza…

Read More »

uniQure and CSL Behring Announce Primary Endpoint Achieved in HOPE-B Pivotal Trial of Etranacogene Dezaparvovec Gene Therapy in Patients with Hemophilia B

Freight App, Inc. Provides 2021 Revenue Guidance of $22 Million to $23 Million

Tiblio Predicts Stock Trends with New Pre-Market Trading Tool

Impact Communications Founder and CEO Marie Swift Receives 2021 Luminaries Award

Lee Enterprises Board of Directors Unanimously Rejects Unsolicited Proposal from Alden

First Wave BioPharma Names Brian Feagan, M.D., to Scientific Advisory Board

ADT Completes Acquisition of Sunpro Solar

Jushi Holdings Inc. Opens 27th Nationwide Dispensary, 17th BEYOND / HELLO™ Retail Location in Pennsylvania and Third Store in the Greater Pittsburgh Region through its Subsidiary, Franklin Bioscience – SW LLC

Celona Drives New Changes to Cellular Standards to Automate Roaming Within Private Enterprise Mobile Networks

Intercept Announces Withdrawal of EMA Marketing Authorization Application for Obeticholic Acid for Advanced Liver Fibrosis Due to NASH

ADMA Biologics Provides Update on Global Intellectual Property Portfolio

Embark Expands Operations into Texas and Opens New Autonomous Trucking Hub to Accommodate Rapid Growth in US Sunbelt

Boxed Teams with Google Cloud to Power Global Platform Technology Solutions

Lee Enterprises reports continued revenue and Adjusted EBITDA growth and strong fourth quarter results

Homie Year-In-Review: Rapid Disruption in Housing Market Setting the Stage for 2022 Growth

Entrada Therapeutics Reports Third Quarter 2021 Financial Results

Liquidity Services Announces Fourth Quarter and Fiscal Year 2021 Financial Results

Arhaus Announces Third Quarter 2021 Financial Results